News

Acerus Update

TORONTO, July 10, 2023 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company”) announces that, in…

error: Content is protected !!
google.com, pub-8062812296869199, DIRECT, f08c47fec0942fa0